The renal manifestations of systemic lupus erythematosus in childhood range
from minor abnormalities detected on urinalysis to severe renal insufficie
ncy requiring renal replacement therapy. Clinically significant renal invol
vement in systemic lupus erythematosus is more common in children than in a
dults. Effective treatment for childhood lupus nephritis is available, and
the prognosis for affected children has improved over the course of the las
t 30 years. Corticosteroid therapy remains the cornerstone of treatment for
children with lupus nephritis. The addition of cytotoxic agents to cortico
steroid treatment improves both the long and short-term prognoses. Cyclospo
rin may improve the clinical manifestations of lupus nephritis although the
disease remains active serologically.
Although survival in childhood lupus has improved, complications of therapy
result in significant morbidity with distressing frequency. Immunosuppress
ion may result in mortality and morbidity due to opportunistic infections.
Individuals with otherwise successful control of renal manifestations of sy
stemic lupus erythematosus may still be left with significant morbidity due
to disturbances in growth due to long-term corticosteroid treatment. Psych
osocial development may be adversely affected both as a result of chronic i
llness as well as due to the effects of therapy. Meticulous attention to de
tail over decades of treatment is necessary to optimize patient outcome in
childhood lupus nephritis.